Small Cap Breaking News: Don’t Miss Today’s Top Headlines 01/22/2025

AGORACOM Small Cap CEO Interviews

🚨 Small Cap Breaking News You Can’t Miss! 🚨
Here’s a quick rundown of the latest updates from standout small-cap companies making big moves today.

ImagineAR is setting a new standard in immersive technology with its AI/AR-as-a-Service platform. This innovation blends generative AI and augmented reality to deliver interactive customer experiences. Key features include AI-driven AR ads, voice-activated AR avatars, and industry-specific applications for retail, casinos, and entertainment. CEO Alen Paul Silverrstieen says, “Our platform empowers businesses to deliver transformative experiences once unimaginable.” With a SaaS subscription model, ImagineAR is positioned for sustainable growth.

VSBLTY and Bitmine AI have teamed up to redefine retail data monetization. By integrating advanced analytics with surveillance technology, they enable retailers to generate new revenue streams from customer engagement data. The partnership is already scaling to 10,000 convenience store locations, offering immediate data profits and long-term advertising revenue potential. CEO Jay Hutton calls it “a game-changer for retailers operating on tight margins.”

Sokoman Minerals has unveiled exceptional drill results at its Moosehead Gold Project in Newfoundland. Assays show high-grade gold, including 176.47 g/t over 1.90 meters, confirming strong mineralization in the Western Trend zone. With consistent exploration success, Sokoman is solidifying its position in Newfoundland’s gold boom, signaling strong potential for 2025 and beyond.

Cassiar Gold’s latest drill results at the Newcoast Prospect in British Columbia highlight significant mineralization potential. Notable results include 141.4 meters of 0.89 g/t gold, indicating similarities to the company’s Taurus deposit. Cassiar continues to unlock value across its property, bolstering investor confidence and positioning itself as a leader in large-scale gold exploration.

Borealis Mining reported gold production of 550 ounces from its fully permitted Nevada mine. With operational infrastructure in place, the company is well-positioned to capitalize on record gold prices. Plans to crush additional stockpiles further enhance its growth potential, signaling a strong year ahead.

Medexus Pharmaceuticals has secured FDA approval for GRAFAPEX™ (treosulfan) for injection, marking a breakthrough in stem cell transplantation for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) patients. With Orphan Drug Designation, Medexus anticipates regulatory exclusivity for up to 7.5 years and a commercial launch in early 2025. Projected to generate over $100 million annually within five years, this innovative treatment boasts improved survival rates and fewer side effects, promising a brighter future for patients and significant growth potential for Medexus.

Want more breaking small-cap news?
Follow AGORACOM for updates, insights, and discussions with industry leaders! 🎧 Check out our podcast: AGORACOM on Spotify.

Stay tuned for more updates!

ImagineAR (CSE: IP): Transforming Customer Engagement with AI/AR-as-a-ServiceVSBLTY (CSE: VSBY) and Bitmine AI: Revolutionizing Retail Data MonetizationSokoman Minerals (TSXV: SIC): High-Grade Gold at Moosehead ProjectCassiar Gold (TSXV: GLDC): Expanding Potential at Newcoast ProspectBorealis Mining (TSXV: BOGO): Boosting Gold Production Amid Record Prices